Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107220
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107220
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107220
Table 3 Relative risks in the study population of the need for oxygen therapy or of forced vital capacity and forced expiratory volume in one second/forced vital capacity < 0.70 at follow-up Source: Regional Health Agency Sprint data
Variable | Level | Raw RR | RR adjusted for age and gender | RRs adjusted for age and gender RRs adjusted for age, gender, days after discharge | |||||||||
RR | Min | Mx | P value | RR | Min | Mx | P value | RR | Min | Mx | P value | ||
Class of age | 18-49 | 1.00 | 1.00 | 1.00 | |||||||||
50-59 | 1.22 | 0.66 | 2.27 | 0.521 | 1.18 | 0.63 | 2.18 | 0.606 | 1.17 | 0.63 | 2.16 | 0.617 | |
60-69 | 1.45 | 0.80 | 2.63 | 0.218 | 1.40 | 0.77 | 2.54 | 0.269 | 1.43 | 0.79 | 2.59 | 0.234 | |
70-79 | 2.95 | 1.71 | 5.10 | 0.000 | 2.93 | 1.70 | 5.07 | 0.000 | 2.81 | 1.63 | 4.85 | 0.000 | |
80+ | 3.61 | 1.99 | 6.54 | 0.000 | 3.60 | 1.99 | 6.52 | 0.000 | 3.25 | 1.81 | 5.84 | 0.000 | |
Gender | Male | 1.00 | 1.00 | 1.00 | |||||||||
Female | 0.84 | 0.62 | 1.12 | 0.234 | 0.77 | 0.57 | 1.03 | 0.078 | 0.82 | 0.62 | 1.09 | 0.165 | |
Chronic illnesses | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 1.17 | 0.88 | 1.54 | 0.282 | 0.93 | 0.70 | 1.24 | 0.629 | 1.00 | 0.76 | 1.31 | 0.983 | |
Chronic obstructive pulmonary disease | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 2.19 | 1.35 | 3.55 | 0.001 | 1.62 | 0.99 | 2.64 | 0.053 | 1.46 | 0.92 | 2.32 | 0.109 | |
Cardiovascular diseases | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 1.24 | 0.77 | 1.98 | 0.376 | 0.97 | 0.61 | 1.54 | 0.890 | 0.97 | 0.61 | 1.55 | 0.914 | |
Diabetes | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 1.22 | 0.82 | 1.81 | 0.322 | 1.13 | 0.76 | 1.67 | 0.545 | 1.13 | 0.76 | 1.66 | 0.552 | |
Hypertension | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 0.91 | 0.63 | 1.32 | 0.620 | 0.80 | 0.56 | 1.15 | 0.227 | 0.87 | 0.61 | 1.25 | 0.456 | |
Neurological diseases | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 0.62 | 0.09 | 4.06 | 0.616 | 0.36 | 0.05 | 2.38 | 0.289 | 0.45 | 0.07 | 3.03 | 0.412 | |
Tumors | No | 1.00 | 1.00 | 1.00 | |||||||||
Yes | 1.47 | 0.74 | 2.89 | 0.270 | 1.35 | 0.70 | 2.59 | 0.371 | 1.36 | 0.71 | 2.63 | 0.355 | |
Smoking | No | 1.00 | 1.00 | 1.00 | |||||||||
Ex smoker | 0.59 | 0.32 | 1.10 | 0.099 | 0.55 | 0.30 | 1.01 | 0.054 | 0.56 | 0.33 | 0.95 | 0.033 | |
Smoker | 0.52 | 0.28 | 0.97 | 0.039 | 0.58 | 0.32 | 1.06 | 0.074 | 0.61 | 0.35 | 1.07 | 0.087 | |
Days to discharge | < 90 | 1.00 | 1.00 | 1.00 | |||||||||
90-179 | 0.42 | 0.29 | 0.61 | 0.000 | 0.52 | 0.37 | 0.74 | 0.000 | 0.52 | 0.37 | 0.74 | 0.000 | |
180-269 | 0.26 | 0.18 | 0.39 | 0.000 | 0.31 | 0.22 | 0.46 | 0.000 | 0.31 | 0.22 | 0.46 | 0.000 | |
270-359 | 0.26 | 0.14 | 0.51 | 0.000 | 0.33 | 0.18 | 0.63 | 0.001 | 0.33 | 0.18 | 0.63 | 0.001 | |
360+ | 0.16 | 0.07 | 0.40 | 0.000 | 0.21 | 0.08 | 0.51 | 0.001 | 0.21 | 0.08 | 0.51 | 0.001 | |
Body mass index | Normal weight/underweight | 1.00 | 1.00 | 1.00 | |||||||||
Overweight | 0.38 | 0.22 | 0.63 | 0.000 | 0.38 | 0.23 | 0.64 | 0.000 | 0.38 | 0.24 | 0.62 | 0.000 | |
Obese | 0.85 | 0.54 | 1.36 | 0.512 | 1.02 | 0.64 | 1.63 | 0.922 | 0.93 | 0.63 | 1.37 | 0.714 |
- Citation: Silvestri C, Stasi C, Profili F, Bartolacci S, Sessa E, Tacconi D, Villari L, Carrozzi L, Dotta F, Bargagli E, Donnini S, Masotti L, Rasero L, Lavorini F, Pistelli F, Chimera D, Sorano A, D'alessandro M, Pacifici M, Milli C, Voller F. Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany. World J Exp Med 2025; 15(3): 107220
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/107220.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.107220